Continental Advisors LLC Pfizer Inc Transaction History

Continental Advisors LLC

$228 Million
Q2 2024

A detailed history of Continental Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Continental Advisors LLC holds 320,000 shares of PFE stock, worth $9.31 Million. This represents 3.93% of its overall portfolio holdings.

Number of Shares

320,000

Previous 342,192 6.49%

Holding current value

$9.31 Million

Previous $9.5 Million 5.71%

% of portfolio

3.93%

Previous 3.84%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $1.49 Million - $1.75 Million	-59,000 Reduced 17.24%	283,192 $7.92 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $3.48 Million - $4 Million	134,400 Added 64.68%	342,192 $9.5 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $1.11 Million - $1.44 Million	-42,500 Reduced 16.98%	207,792 $5.98 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $1.78 Million - $2.09 Million	55,600 Added 28.56%	250,292 $8.3 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $1.18 Million - $1.37 Million	32,800 Added 20.26%	194,692 $7.14 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $1.55 Million - $2.01 Million	39,254 Added 32.01%	161,892 $6.61 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $1.13 Million - $1.47 Million	-26,964 Reduced 18.02%	122,638 $6.29 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $186,120 - $220,680	-4,000 Reduced 2.6%	149,602 $7.84 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $2.75 Million - $3.4 Million	60,000 Added 64.1%	153,602 $7.95 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $409,068 - $606,375	-9,900 Reduced 9.57%	93,602 $5.53 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $1.65 Million - $2.12 Million	-42,100 Reduced 28.91%	103,502 $4.45 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $538,650 - $610,200	-15,000 Reduced 9.34%	145,602 $5.7 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $1.81 Million - $2.04 Million	54,000 Added 50.66%	160,602 $5.82 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $167,350 - $212,800	5,000 Added 4.92%	106,602 $3.92 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $95,250 - $111,750	3,000 Added 3.04%	101,602 $3.73 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $180,720 - $219,240	6,000 Added 6.48%	98,602 $3.22 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $54,060 - $77,240	2,000 Added 2.21%	92,602 $3.02 Million
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $368,638 - $418,357	-11,198 Reduced 11.0%	90,602 $3.55 Million
Q3 2019 Oct 28, 2019	BUY	$32.49 - $42.13 $243,675 - $315,975	7,500 Added 7.95%	101,800 $3.66 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $3.08 Million - $3.39 Million	-82,201 Reduced 46.57%	94,300 $4.01 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $384,700 - $438,600	-10,000 Reduced 5.36%	176,501 $7.7 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $692,847 - $840,381	-20,100 Reduced 9.73%	186,501 $8.22 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $159,550 - $185,100	-5,000 Reduced 2.36%	206,601 $7.33 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $565,420 - $599,930	-17,000 Reduced 7.44%	211,601 $7.66 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $7.09 Million - $7.81 Million	228,601	228,601 $8.16 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continental Advisors LLC with notifications on news.

Account

Continental Advisors LLC Pfizer Inc Transaction History